Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors

Abstract The combination of hypomethylating agents (HMA) and venetoclax (VEN) has transformed acute myeloid leukemia (AML) treatment. Data on donor lymphocyte infusion (DLI) with HMA/VEN for relapse after allogeneic hematopoietic cell transplantation (alloHCT) remain limited. We retrospectively anal...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Miriam Mozaffari Jovein, Thomas Meyer, Miguel Waterhouse, Dietmar Pfeifer, Jesús Duque-Afonso, Michael Lübbert, Kristina Maas-Bauer, Ralph Wäsch, Hartmut Bertz, Justus Duyster, Robert Zeiser, Jürgen Finke, Claudia Wehr
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Springer 2026-03-01
Sarja:	Annals of Hematology
Aiheet:	Allogeneic stem cell transplantation Relapsed AML Myeloid neoplasms Hypomethylating agents Donor lymphocyte infusions Venetoclax
Linkit:	https://doi.org/10.1007/s00277-026-06973-7
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!